The FDA approved expanded access for Revolution Medicines' experimental pancreatic cancer drug, allowing eligible patients to receive the investigational treatment outside standard trials.
← News
Medicine Breakthroughs Medicine Breakthroughs Health
FDA Permits Expanded Access for Investigational Pancreatic Cancer Drug | FDA
Investigational Pancreatic Cancer Treatment Drug type
FDA Expanded Access Approval (EAP) Regulatory action
Revolution Medicines Sponsor